V3 Viral Defense Nano Silver Skin Protectant

Manufacturer
Core Pacific, Inc.
Effective date
2020-07-17
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:23:21

Label at a glance#

ProductV3 Viral Defense Nano Silver Skin Protectant
Active ingredientBENZALKONIUM CHLORIDE
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Benzalkonium Chloride 0.1%

PURPOSE

OTC - PURPOSE SECTION

Antimicrobial

INDICATIONS & USAGE SECTION

Uses: Sanitizes and protects skin to help reduce viruses and bacteria that cause disease.

WARNINGS SECTION

WARNINGS: For external use only.

Do not use in eyes. If contact occurs, flush thoroughly with water.

Stop use and ask a doctor: If irritation or redness develops, or if condition persist for more than 72 hours.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children: If swallowed, get medical help or contact a Poison Control Center.

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS: On dry skin, apply enough product to thoroughly cover the areas to be protected and allow to dry. If abrasively washed reapply as needed.

INACTIVE INGREDIENT SECTION

Other Ingredients: structured water, nano colloidal silver, organosilane, sodium sesquicarbonate, fulvic acid, magnesium

SPL UNCLASSIFIED SECTION

• NON-ALCOHOL

• GUARDS AGAINST INFECTION

• ECO-FRIENDLY

• DOESN'T DRY OR CRACK YOUR SKIN

99.99% EFFECTIVE AGAINST BACTERIA, VIRUSES & MOST COMMON GERMS.

24 HOUR SKIN PROTECTION

POWERED BY: V3 PROPRIETARY TECHNOLOGY

Manufactured by:

Core Pacific, Inc for

V3 International Inc.

4000 Leeland St

Houston, TX 77003

www.v3viraldefense.com

1-888-462-4928   

MADE IN USA.

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

IMAGE1IMAGE1IMAGE2IMAGE2IMAGE3IMAGE3IMAGE5IMAGE5IMAGE4IMAGE4IMAGE6IMAGE6

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1038791benzalkonium chloride 0.1 % Topical SolutionPSN1
1038791benzalkonium chloride 1 MG/ML Topical SolutionSCD1
1038791benzalkonium chloride 0.1 % Topical SolutionSY1

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
79518-100-01V3 Viral Defense Nano Silver Skin Protectant59.14 mL in 1 BOTTLE, SPRAYLIQUID59.141
79518-100-02V3 Viral Defense Nano Silver Skin Protectant250 mL in 1 BOTTLE, SPRAYLIQUID2501
79518-100-03V3 Viral Defense Nano Silver Skin Protectant1000 mL in 1 BOTTLE, SPRAYLIQUID10001
79518-100-04V3 Viral Defense Nano Silver Skin Protectant3785 mL in 1 BOTTLELIQUID37851
79518-100-05V3 Viral Defense Nano Silver Skin Protectant208198 mL in 1 DRUMLIQUID2081981

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
79518-100V3 VIRAL DEFENSE NANO SILVER SKIN PROTECTANT (BENZALKONIUM CHLORIDE) LIQUID [CORE PACIFIC, INC.]1Legacy NDC, 5 package rows20200801_5bd5fee0-74f5-4690-b247-485d0d606892.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
79518-10079518-100-01, 79518-100-02, 79518-100-03, 79518-100-04, 79518-100-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d14caddc-037d-4023-9836-4d8353ea61385bd5fee0-74f5-4690-b247-485d0d6068922020-07-17WarningsExact identifier
spl id: d14caddc-037d-4023-9836-4d8353ea6138
spl set id: 5bd5fee0-74f5-4690-b247-485d0d606892

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.